Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGRX | PSNL | ACST | ||
| Company | Agile Therapeutics Inc | Personalis Inc | Acasti Pharma | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.4193 | 1.2600 | 2.84 | ||
| High | 0.4297 | 1.3700 | 2.84 | ||
| Low | 0.4000 | 1.2600 | 2.66 | ||
| Last | 0.4297 | 1.3600 | 2.68 | ||
| Change | +0.0297 | +0.0950 | -0.22 | ||
| % Change | +7.42% | +7.51% | -7.59% | ||
| Volume | 72,900 | 149,700 | 6,800 | ||
| 20-Day Average Volume | 105,295 | 207,320 | 14,595 | ||
| Previous Close | 0.4000 | 1.2650 | 2.90 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3650 | 1.3205 | 3.18 | ||
| 20-Day Raw Stochastic | 99.83% | 62.07% | 2.38% | ||
| 20-Day Relative Strength | 41.66% | 48.82% | 27.19% | ||
| Weighted Alpha | -90.00 | -61.03 | -35.90 | ||
| Today's Opinion | 88% Sell | 56% Sell | 8% Buy | ||
| Previous Opinion | 88% Sell | 72% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.06% since 04/22/24 | +7.94% since 04/22/24 | -5.96% since 04/22/24 | ||
| Low | 0.3610 on 04/24/24 | 1.1800 on 04/25/24 | 2.66 on 04/29/24 | ||
| High | 0.4300 on 04/26/24 | 1.4199 on 04/23/24 | 3.16 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | +26.38% since 03/28/24 | -8.72% since 03/28/24 | -21.75% since 03/28/24 | ||
| Low | 0.2220 on 04/01/24 | 1.1800 on 04/25/24 | 2.66 on 04/29/24 | ||
| High | 0.4300 on 04/26/24 | 1.5400 on 04/01/24 | 3.50 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | -73.14% since 01/29/24 | -11.11% since 01/29/24 | +7.20% since 01/29/24 | ||
| Low | 0.2000 on 03/26/24 | 1.1200 on 02/08/24 | 2.25 on 02/05/24 | ||
| High | 1.6600 on 01/30/24 | 1.8000 on 03/13/24 | 3.59 on 02/22/24 | ||
| 6-Month | |||||
| %Chg | -75.45% since 10/27/23 | +40.19% since 10/27/23 | +11.67% since 10/27/23 | ||
| Low | 0.2000 on 03/26/24 | 0.8906 on 11/10/23 | 1.98 on 01/17/24 | ||
| High | 2.6063 on 12/04/23 | 2.3800 on 12/28/23 | 3.59 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,742 | 63,888 | 27,258 | ||
| Shares Outstanding, K | 6,856 | 50,504 | 9,399 | ||
| Annual Sales | 19,590,000 | 73,480,000 | 0 | ||
| Annual Net Income | -14,470,000 | -108,300,000 | -42,430,000 | ||
| Last Quarter Sales | 3,620,000 | 19,680,000 | 0 | ||
| Last Quarter Net Income | -4,470,000 | -26,580,000 | -2,390,000 | ||
| 60-Month Beta | 1.42 | 1.95 | 1.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.46 on 03/28/24 | -0.46 on 02/28/24 | -0.21 on 02/12/24 | ||
| Latest Earnings Date | 05/09/24 | 05/08/24 | 02/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||